Brar Balbir 5
5 · Imprimis Pharmaceuticals, Inc. · Filed Mar 15, 2013
Insider Transaction Report
Form 5
Brar Balbir
Director
Transactions
- Award
Option (Right to Buy)
2012-02-28+225,000→ 225,000 totalExercise: $3.68Exp: 2016-02-28→ Common Stock (225,000 underlying) - Award
Option (Right to Buy)
2012-04-01+25,000→ 25,000 totalExercise: $4.50Exp: 2017-03-31→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The stock option was granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests over a three year period, with 1/36th of the total number of options vesting each monthly period beginning on February 23, 2012. The option was approved by the Issuer's Board of Directors on January 23, 2012, subject to shareholder approval of an amendment to the Plan, which was obtained on February 28, 2012.
- [F2]The stock options were granted under the Plan and vest over a 1 year period, with the initial 6,250 options vesting on June 30, 2012, the next 6,250 options vesting on September 30, 2012, the next 6,250 options vesting on December 31, 2012 and the final 6,250 options vesting on March 31, 2013.